Swiss longevity biotech company Timeline (parent company Amazentis) announced that it has raised CHF 56 million (US$ 66 million) in an oversubscribed Series D financing round that included strategic investments by L’Oréal and Nestlé.
L'Oréal has revealed details of a new license agreement with Dutch biotech firm Micreos that gives the cosmetics giant access to technology, which targets the bacteria responsible for skin conditions.